Nephros, Inc. (NEPH)
3.21
-0.01
(-0.31%)
USD |
NASDAQ |
May 07, 15:44
Nephros SG&A Expense (TTM) : 9.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Cerus Corp. | 80.58M |
| Xtant Medical Holdings, Inc. | 74.89M |
| Abbott Laboratories | 13.01B |
| Accuray, Inc. | 88.55M |
| Plus Therapeutics, Inc. | 12.13M |